NEW YORK (

TheStreet

) --

Perrigo Company

(NYSE:

PRGO

) hit a new 52-week high Friday as it is currently trading at $155.14, above its previous 52-week high of $155.08 with 42,133 shares traded as of 9:50 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.

Perrigo has a market cap of $14.41 billion and is part of the health care sector and drugs industry. Shares are up 49% year to date as of the close of trading on Thursday.

Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API). The company has a P/E ratio of 32.2, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates

Perrigo

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full

Perrigo Ratings Report

.

See all

52-week high stocks

or get investment ideas from our

investment research center

.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more

.

null